Loading organizations...

§ Venture Capital · Israel
Venture capital firm and investment platform investing in early-stage Israeli tech startups, focused on climate, health, and food tech.
iAngels is a venture capital firm and investment platform based in Tel Aviv, Israel, that invests in early-stage Israeli tech startups. The firm primarily focuses on seed rounds, deploying checks typically between $2-4 million, with an emphasis on double-bottom-line companies across sectors like climate tech, health tech, and food tech. Initially operating as a platform for accredited investors to participate in private rounds, iAngels now also raises institutional venture capital funds. It manages over $300 million in assets, having raised $55.5 million for its first institutional fund in 2021, anchored by the European Investment Fund, and recently secured $70 million for its second fund. The firm has executed 56 transactions in 2021, resulting in 13 exits, and continues to support its portfolio through due diligence. iAngels was founded in 2014 by Mor Assia, Shelly Hod Moyal, and David Assia.
iAngels has raised $2.3M across 1 funding round.
Key people at iAngels.
iAngels has raised $2.3M in total across 1 funding round.
Key people at iAngels.
iAngels has raised $2.3M in total across 1 funding round.
iAngels's investors include Millhouse Capital, Alex Waislitz, Boaz Weinstein, Daniel Recanati, David Assia, Drew Schaefer, Gigi Levy Weiss, Marc Lasry, Marcy Simon, Yanki Margalit.
iAngels is a women-led, next-generation venture capital firm based in Tel Aviv, Israel, focused on democratizing access to high-potential Israeli tech startups. Its mission is to transform venture investing from an intuition-driven art into a data-driven science, offering institutional-grade tools and curated opportunities to a global network of accredited and institutional investors. iAngels specializes in early-stage technology companies, with a strong emphasis on artificial intelligence, fintech, health & wellness, HR tech, and software. Through its proprietary research and rigorous due diligence, the firm builds uniquely curated portfolios that aim to generate strong returns while supporting the growth of Israel’s most promising entrepreneurs.
The firm plays a significant role in the Israeli startup ecosystem by acting as a bridge between global capital and Israeli innovation. It invests across seed, Series A, and Series B stages, backing companies that often go on to become category leaders. With over 90 investments and 24 profitable exits to date, iAngels has established itself as a top-tier player in Israel’s venture landscape, helping fuel the growth of now-iconic companies like Via and Lemonade while also supporting social impact initiatives such as Save a Child’s Heart and the Israel Cancer Research Fund.
---
Founded in 2014 by Shelly Hod Moyal and Mor Assia, iAngels emerged from a shared vision: to make elite Israeli venture opportunities accessible beyond traditional closed networks. Both founders brought deep experience in tech investing and entrepreneurship, having spent years navigating Israel’s vibrant but often opaque startup scene. They recognized that many high-caliber Israeli startups struggled to scale without broader access to global capital, while international investors lacked reliable, curated pathways into the ecosystem.
From the beginning, iAngels was designed as a hybrid model—part venture capital firm, part investment platform. Rather than operating solely as a single fund, it created a structure where investors could access a vetted pipeline of Israeli startups, supported by comprehensive due diligence and ongoing portfolio monitoring. Over time, the firm expanded its offerings into tailored products like iAngels Capital (self-directed accounts), iAngels Ventures (personalized “mini-funds”), and iAngels Digital Assets (blockchain-focused strategies), evolving into a full-service gateway for global investors seeking exposure to Israeli innovation.
---
Data-Driven, Institutional-Grade Approach- Built proprietary research and due diligence frameworks to systematically evaluate startups, reducing reliance on gut feel.- Applies asset management rigor to venture investing, appealing to sophisticated investors who expect transparency and process.
Curated Access to Israeli Tech- Focuses exclusively on Israel’s deep tech and innovation ecosystem, leveraging local presence and relationships to source top-tier deals.- Offers investors “insider access” to pre-vetted opportunities across AI, fintech, health tech, and software, often at early stages.
Flexible Investment Products- iAngels Capital: Self-directed accounts for experienced investors who want control and full access to due diligence materials.- iAngels Ventures: Professionally managed, diversified portfolios tailored to an investor’s risk profile and preferences.- iAngels Digital Assets: Actively managed blockchain and digital asset strategy, reflecting early recognition of Web3’s potential.
Strong Network & Ecosystem Role- Deep ties to Israel’s tech ecosystem, including founders, accelerators, and later-stage investors.- Provides ongoing support to portfolio companies, helping them scale through introductions, strategic guidance, and follow-on funding.
Track Record & Social Impact- Over 90 investments and 24 profitable exits, including marquee names like Via and Lemonade.- Actively supports social causes and encourages employee volunteering, reinforcing a values-driven culture within a high-performance VC model.
---
iAngels sits at the intersection of three powerful trends: the globalization of venture capital, the rise of Israel as a deep tech powerhouse, and the institutionalization of angel/early-stage investing. As more investors seek diversification beyond Silicon Valley, Israel’s concentration of AI, cybersecurity, and fintech talent has become increasingly attractive. iAngels capitalizes on this demand by packaging Israeli innovation into structured, accessible products that feel familiar to traditional investors.
The firm also reflects a broader shift toward democratization in venture—moving away from opaque, relationship-dependent deal flow toward transparent, research-backed platforms. By combining a women-led perspective with a data-oriented approach, iAngels challenges traditional VC norms while amplifying Israel’s role as a global innovation hub. Its success demonstrates that rigorous process, combined with deep local insight, can scale early-stage investing without sacrificing returns.
Moreover, iAngels’ expansion into digital assets shows its ability to anticipate and adapt to emerging technological waves, positioning it not just as a gatekeeper to Israeli startups, but as a forward-looking investment partner in the broader tech transformation.
---
Looking ahead, iAngels is well-positioned to deepen its role as a bridge between global capital and Israeli innovation. As more institutional investors allocate to venture and alternative assets, the demand for curated, transparent, and professionally managed exposure to high-growth tech ecosystems will only grow. iAngels’ hybrid model—offering both self-directed and managed options—puts it in a strong spot to capture this shift, especially as it continues to refine its data-driven processes and expand its digital assets strategy.
The firm’s future will likely be shaped by how it navigates several key dynamics: scaling its platform without diluting deal quality, maintaining its edge in an increasingly competitive Israeli VC market, and continuing to attract top-tier founders amid rising global competition for deep tech. If it sustains its focus on excellence, transparency, and ecosystem impact, iAngels could evolve from a leading Israeli VC into a global brand for smart, accessible venture investing.
In a world where access to innovation is becoming the ultimate competitive advantage, iAngels’ mission—to turn venture investing into a science and open it to more investors—feels not just timely, but essential.
iAngels has raised $2.3M across 1 funding round. Most recently, it raised $2.3M Seed in March 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 24, 2015 | $2.3M Seed | Millhouse Capital | Alex Waislitz, Boaz Weinstein, Daniel Recanati, David Assia, Drew Schaefer, Gigi Levy Weiss, Marc Lasry, Marcy Simon, Yanki Margalit | Announced |